To earn CME related to this news article, click here. January 21, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise of the potential for ...

June 9, 2005 — The U.S. Food and Drug Administration (FDA) has approved a capsule formulation of paricalcitol for the prevention and treatment of secondary hyperparathyroidism in patients with stage ...

New Delhi, Dec 27 (PTI) Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market its generic version of Fondaparinux Sodium injection used to ...

PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. MYL, +0.23% today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, ...

Low-molecular-weight heparin remains the anticoagulant of choice for pregnant women with previous thromboembolic events. Fondaparinux (Arixtra, Sanofi-Synthelabo) is a chemically synthesized ...

HYDERABAD, India & BRISBANE, Australia--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) and Alchemia Limited, Brisbane, Australia (ASX: ACL) announced today that Dr. Reddy’s has received final ...

BRISBANE, Australia--(BUSINESS WIRE)--Alchemia (ASX:ACL) today announced the agreement of terms with Dr Reddy’s Limited for marketing fondaparinux sodium for injection (the generic version of ...

Mylan Inc. ( MYL) is all set to acquire the U.S. commercialization, marketing and intellectual property rights to Arixtra injection from Aspen Global Incorporated for $225 million (initial payment).

Provides Another Important and Highly Complex Injectable to Complement Mylan Institutional's Growing Portfolio in the U.S. PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today ...

NEW DELHI: Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market its generic version of Fondaparinux Sodium injection used to prevent deep ...

Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market its generic version of Fondaparinux Sodium injection used to prevent deep vein ...

PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, marketing and ...